These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 4478030)
21. [Clinical use of an estro-progestinic association in "sequential" treatment]. Scaglione V; Arrotta U Attual Ostet Ginecol; 1968; 14(6):467-88. PubMed ID: 5738121 [No Abstract] [Full Text] [Related]
22. [Clinical considerations on a new estro-progestin combination: ethinylestradiol-medroxyprogesterone acetate]. Bailo U; Valsecchi A Minerva Ginecol; 1965 Sep; 17(17):890-3. PubMed ID: 5852444 [No Abstract] [Full Text] [Related]
23. [Therapeutic trend in acne associated with the menstrual cycle]. Cersosimo L; Iannucci D; Consalvo F; Orgiu G Clin Ter; 1983 Jun; 105(5):411-4. PubMed ID: 6223780 [No Abstract] [Full Text] [Related]
25. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy. Franks S; Layton A; Glasier A Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746 [TBL] [Abstract][Full Text] [Related]
26. [Triella: a French multicenter double blind clinical study]. Castaigne JP Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):445-53. PubMed ID: 12280213 [TBL] [Abstract][Full Text] [Related]
27. [Tolerance of the gestagen-estrogen combination Noracyclin in contraception and gynecologic indications]. Willmes HG Med Klin; 1967 Jun; 62(24):951-4. PubMed ID: 5627276 [No Abstract] [Full Text] [Related]
28. [Clinical and biological experience with a new norsteroid: SH 513]. Lévrier M Gynecol Prat; 1964; 15(1):29-36. PubMed ID: 5878723 [No Abstract] [Full Text] [Related]
29. Post coital contraception--A pilot study. Yuzpe AA; Thurlow HJ; Ramzy I; Leyshon JI J Reprod Med; 1974 Aug; 13(2):53-8. PubMed ID: 4844513 [TBL] [Abstract][Full Text] [Related]
31. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse). Barbosa IC; Filho CI; Faggion D; Baracat EC Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291 [TBL] [Abstract][Full Text] [Related]
32. [Use of a synthetic estro-progestational hormone: C. S. 1516 in gynecologic therapeutics. Apropos of 39 cases]. Guilhem P; Pontonnier A; Monrozies M; Pontonnier G; Bardenat M Bull Fed Soc Gynecol Obstet Lang Fr; 1966; 18(3):327-33. PubMed ID: 4164208 [No Abstract] [Full Text] [Related]
34. [Extended clinical studies on a new biphasic preparation]. Lachnit U Ther Ggw; 1974 Sep; 113(9):1486-505. PubMed ID: 4612855 [TBL] [Abstract][Full Text] [Related]
35. Added benefits of drospirenone for compliance. Foidart JM Climacteric; 2005 Oct; 8 Suppl 3():28-34. PubMed ID: 16203653 [TBL] [Abstract][Full Text] [Related]
36. Perimenopausal patients: treatment with continual escalating-dose synthetic estrogen with added progestogen. Roland M; Stubbs S; Ober WB Geriatrics; 1972 May; 27(5):138-45. PubMed ID: 5022804 [No Abstract] [Full Text] [Related]
37. [Clinical study and effect on the uterine receptor of the combination Norgestrel-Ethinyl-Estradiol (FH 122-A) in 500 menstrual cycles]. Lévrier M Bord Med; 1970 Jan; 3(1):225-6. PubMed ID: 4948561 [No Abstract] [Full Text] [Related]